Square Pharmaceuticals (DHA:SQURPHARMA) Ending Cash Position : BDT57,663 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals Ending Cash Position?

Square Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 was BDT57,663 Mil.

Square Pharmaceuticals's quarterly Ending Cash Position increased from Jun. 2023 (BDT50,094 Mil) to Sep. 2023 (BDT56,752 Mil) and increased from Sep. 2023 (BDT56,752 Mil) to Dec. 2023 (BDT57,663 Mil).

Square Pharmaceuticals's annual Ending Cash Position increased from Jun. 2021 (BDT43,364 Mil) to Jun. 2022 (BDT48,962 Mil) and increased from Jun. 2022 (BDT48,962 Mil) to Jun. 2023 (BDT50,094 Mil).

Square Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Square Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals Ending Cash Position Chart

Square Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

27,004.04

32,564.33

43,364.04

48,962.50

50,094.32

Square Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															55,624.39	50,490.88	50,094.32	56,752.06	57,663.20

Square Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Square Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	48962.498	+	1131.824
	=	50,094

Square Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	56561.981	+	1101.223
	=	57,663

Square Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Square Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Square Pharmaceuticals (DHA:SQURPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212

Website

http://www.squarepharma.com.bd

Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. The company operates in Bangladesh and sells its products locally and internationally. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs.

Square Pharmaceuticals (DHA:SQURPHARMA) Headlines

No Headlines